FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077120308> ?p ?o ?g. }

• W2077120308 endingPage "60" @default.
• W2077120308 startingPage "51" @default.
• W2077120308 abstract "One hundred and one soft tissue sarcoma patients from an adjuvant chemotherapy study of the Surgery Branch, National Cancer Institute who had received greater than or equal to 430 mg/m2 (range, 430-600 mg/m2) of doxorubicin were followed for evidence of cardiomyopathy. Fourteen patients developed clinical congestive heart failure attributable to doxorubicin. Nine of these fourteen were evaluated by radionuclide angiography (RNA), and all were abnormal with mean ejection fraction both at rest and exercise less than 30%. Sixty-one asymptomatic patients were studied at least once with RNA. In this asymptomatic group, 13 of 61 patients (21%) had abnormal resting left ventricular function. Exercise studies identified an additional 19 abnormal individuals (31%). Overall incidence of cardiomyopathy, as evidenced by RNA, in the asymptomatic group was 52%. By including the fourteen symptomatic patients, the incidence of cardiomyopathy detected either clinically or by RNA in the 75 evaluated patients was 46%. Comparison of patients by age (less than 40 versus greater than 40) revealed a highly significant difference in the incidence of cardiomyopathy (P less than .001). Fourteen of 36 patients (38%) less than or equal to 40 had either clinical or RNA evidence of cardiotoxicity while 32 of 39 (82%) individuals greater than 40 demonstrated cardiomyopathy. No significant difference was seen in those asymptomatic patients in whom RNA was performed less than or equal to 12 months as compared with greater than 12 months after the end of doxorubicin treatment. In the entire group there was no apparent improvement in cardiomyopathy with time, but results suggest that left ventricular function in the group older than 40 years does deteriorate. The cardiac function of patients younger than age 40 appeared to remain stable or possibly improve with time after the completion of treatment. Sex, tumor location, and radiation treatment were not associated with an increased risk of cardiomyopathy. These results emphasize the dangers of full-dose doxorubicin therapy. This high incidence of cardiomyopathy became apparent because of our ability to prospectively evaluate a large group of patients with prolonged life expectancy that received adjuvant doxorubicin chemotherapy after surgery." @default.
• W2077120308 created "2016-06-24" @default.
• W2077120308 creator A5003311810 @default.
• W2077120308 creator A5007498033 @default.
• W2077120308 creator A5009626268 @default.
• W2077120308 creator A5028576363 @default.
• W2077120308 creator A5033936594 @default.
• W2077120308 creator A5055850072 @default.
• W2077120308 creator A5072133376 @default.
• W2077120308 creator A5088714406 @default.
• W2077120308 date "1983-07-01" @default.
• W2077120308 modified "2023-10-12" @default.
• W2077120308 title "Prospective evaluation of doxorubicin‐induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas" @default.
• W2077120308 cites W1828224642 @default.
• W2077120308 cites W1969262864 @default.
• W2077120308 cites W1977105311 @default.
• W2077120308 cites W1999514033 @default.
• W2077120308 cites W2005408885 @default.
• W2077120308 cites W2010590441 @default.
• W2077120308 cites W2012023177 @default.
• W2077120308 cites W2014152824 @default.
• W2077120308 cites W2014698797 @default.
• W2077120308 cites W2020893327 @default.
• W2077120308 cites W2024013564 @default.
• W2077120308 cites W2026516892 @default.
• W2077120308 cites W2031110542 @default.
• W2077120308 cites W2039642936 @default.
• W2077120308 cites W2046696379 @default.
• W2077120308 cites W2049129583 @default.
• W2077120308 cites W2055063099 @default.
• W2077120308 cites W2058563509 @default.
• W2077120308 cites W2085493687 @default.
• W2077120308 cites W2111426313 @default.
• W2077120308 cites W2129948966 @default.
• W2077120308 cites W2140520845 @default.
• W2077120308 cites W2329319370 @default.
• W2077120308 cites W2335706440 @default.
• W2077120308 cites W4246237837 @default.
• W2077120308 cites W4256407300 @default.
• W2077120308 cites W4293241248 @default.
• W2077120308 cites W4323966495 @default.
• W2077120308 doi "https://doi.org/10.1002/1097-0142(19830701)52:1<51::aid-cncr2820520111>3.0.co;2-#" @default.
• W2077120308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6850545" @default.
• W2077120308 hasPublicationYear "1983" @default.
• W2077120308 type Work @default.
• W2077120308 sameAs 2077120308 @default.
• W2077120308 citedByCount "42" @default.
• W2077120308 crossrefType "journal-article" @default.
• W2077120308 hasAuthorship W2077120308A5003311810 @default.
• W2077120308 hasAuthorship W2077120308A5007498033 @default.
• W2077120308 hasAuthorship W2077120308A5009626268 @default.
• W2077120308 hasAuthorship W2077120308A5028576363 @default.
• W2077120308 hasAuthorship W2077120308A5033936594 @default.
• W2077120308 hasAuthorship W2077120308A5055850072 @default.
• W2077120308 hasAuthorship W2077120308A5072133376 @default.
• W2077120308 hasAuthorship W2077120308A5088714406 @default.
• W2077120308 hasConcept C126322002 @default.
• W2077120308 hasConcept C136948725 @default.
• W2077120308 hasConcept C141071460 @default.
• W2077120308 hasConcept C142724271 @default.
• W2077120308 hasConcept C143998085 @default.
• W2077120308 hasConcept C2776694085 @default.
• W2077120308 hasConcept C2777863537 @default.
• W2077120308 hasConcept C2778198053 @default.
• W2077120308 hasConcept C2778256501 @default.
• W2077120308 hasConcept C2778629024 @default.
• W2077120308 hasConcept C2778797674 @default.
• W2077120308 hasConcept C2781303535 @default.
• W2077120308 hasConcept C71924100 @default.
• W2077120308 hasConceptScore W2077120308C126322002 @default.
• W2077120308 hasConceptScore W2077120308C136948725 @default.
• W2077120308 hasConceptScore W2077120308C141071460 @default.
• W2077120308 hasConceptScore W2077120308C142724271 @default.
• W2077120308 hasConceptScore W2077120308C143998085 @default.
• W2077120308 hasConceptScore W2077120308C2776694085 @default.
• W2077120308 hasConceptScore W2077120308C2777863537 @default.
• W2077120308 hasConceptScore W2077120308C2778198053 @default.
• W2077120308 hasConceptScore W2077120308C2778256501 @default.
• W2077120308 hasConceptScore W2077120308C2778629024 @default.
• W2077120308 hasConceptScore W2077120308C2778797674 @default.
• W2077120308 hasConceptScore W2077120308C2781303535 @default.
• W2077120308 hasConceptScore W2077120308C71924100 @default.
• W2077120308 hasIssue "1" @default.
• W2077120308 hasLocation W20771203081 @default.
• W2077120308 hasOpenAccess W2077120308 @default.
• W2077120308 hasPrimaryLocation W20771203081 @default.
• W2077120308 hasRelatedWork W2048642889 @default.
• W2077120308 hasRelatedWork W2320044361 @default.
• W2077120308 hasRelatedWork W2356429962 @default.
• W2077120308 hasRelatedWork W2386116568 @default.
• W2077120308 hasRelatedWork W2399304731 @default.
• W2077120308 hasRelatedWork W2980708930 @default.
• W2077120308 hasRelatedWork W3030027916 @default.
• W2077120308 hasRelatedWork W4226330015 @default.
• W2077120308 hasRelatedWork W4319965185 @default.
• W2077120308 hasRelatedWork W4366992003 @default.
• W2077120308 hasVolume "52" @default.
• W2077120308 isParatext "false" @default.

• next